End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.04 CNY | +0.74% | -2.33% | -30.17% |
29/04 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/04 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
Evolution of the average Target Price on CanSino Biologics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CanSino Biologics Inc.
UBS |
EPS Revisions
- Stock Market
- Equities
- 6185 Stock
- 688185 Stock
- Consensus CanSino Biologics Inc.